ClinicalTrials.gg
Sign In

Foramen Ovale, Patent clinical trials

The registry lists 136 studies for Foramen Ovale, Patent across more than 10 countries. 47 are recruiting or about to start. 87 of them are mainly about Foramen Ovale, Patent (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-13.

Get an email when these change. Save the Foramen Ovale, Patent studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
43
Recruiting
34
Status unknown
21
Not yet recruiting
12
Terminated
9
Active, not recruiting
8

Phase

Phase 3
10
Phase 2
7
Phase 4
4
Early Phase 1
1

Where

United States
36
Germany
21
China
20
France
15
Canada
14
Italy
11

Who runs them

Abbott Medical Devices (11) · Lifetech Scientific (Shenzhen) Co., Ltd. (6) · W.L.Gore & Associates (4) · Chinese Academy of Medical Sciences, Fuwai Hospital (4) · Cierra (3) · Assistance Publique - Hôpitaux de Paris (3) · University of Oregon (3) · China National Center for Cardiovascular Diseases (3)

What is being tested here

Drugs under test in Foramen Ovale, Patent studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Aspirin002
Flecainide011
Clopidogrel001
Rivaroxaban001
Sildenafil001
Warfarin001
Apixaban001

Drug classes tested here Factor Xa inhibitors 1 open

Coming up

3phase 3 studies under way
12studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 34 Foramen Ovale, Patent studies recruiting now, 11 (32%) set no upper age limit and 19 (56%) stop at 75 or younger. 3 (9%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (6%) take healthy volunteers.

Recruiting studies that take each age, of 34
AgeWomenMen
102 (6%)2 (6%)
1831 (91%)31 (91%)
3032 (94%)32 (94%)
4032 (94%)32 (94%)
5032 (94%)32 (94%)
6527 (79%)27 (79%)
7515 (44%)15 (44%)
8514 (41%)14 (41%)

Across all 136 studies, recruiting or not: 46% stop at 75 or younger and 40% at 65; 16% take children; 0% are for women only and 0% for men only; 9% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Foramen Ovale, Patent studies take

Of 31 interventional studies with no phase under Foramen Ovale, Patent, half reached primary completion within 47 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase47 mo32–100 · 31 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 15, 2026.

Results posted1

Studies

Recruiting first, then most recently updated. Showing 50 of 136. Browse all 136 → or search them.